| Literature DB >> 22940764 |
Agnieszka Maciejewska1, Joanna Jakubowska, Ryszard Pawłowski.
Abstract
Degraded DNA is often analyzed in forensic genetics laboratories. Reliable analysis of degraded DNA is of great importance, since its results impact the quality and reliability of expert testimonies. Recently, a number of whole genome amplification (WGA) methods have been proposed as preamplification tools. They work on the premise of being able to generate microgram quantities of DNA from as little as the quantity of DNA from a single cell. We chose, investigated, and compared seven WGA methods to evaluate their ability to "recover" degraded and nondegraded DNA: degenerate oligonucleotide-primed PCR, primer extension preamplification PCR, GenomePlex™ WGA commercial kit (Sigma), multiple displacement amplification, GenomiPhi™ Amplification kit (Amersham Biosciences), restriction and circularization-aided rolling circle amplification, and blunt-end ligation-mediated WGA. The efficiency and reliability of those methods were analyzed and compared using SGMPlus, YFiler, mtDNA, and Y-chromosome SNP typing. The best results for nondegraded DNA were obtained with GenomiPhi and PEP methods. In the case of degraded DNA (200 bp), the best results were obtained with GenomePlex which successfully amplified also severely degraded DNA (100 bp), thus enabling correct typing of mtDNA and Y-SNP loci. WGA may be very useful in analysis of low copy number DNA or degraded DNA in forensic genetics, especially after introduction of some improvements (sample pooling and replicate DNA typing).Entities:
Mesh:
Substances:
Year: 2012 PMID: 22940764 PMCID: PMC3578730 DOI: 10.1007/s00414-012-0764-9
Source DB: PubMed Journal: Int J Legal Med ISSN: 0937-9827 Impact factor: 2.686
Modifications of PEP, DOP, MDA, and RCA-RCA protocols
| PEP | DOP | MDA | RCA-RCA | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Parameter | Zhang et al. [ | Modified PEP protocol | Parameter | Telenius et al. [ | Modified DOP protocol | Parameter | Dean et al. [ | Modified MDA protocol | Parameter | Wang et al. [ | Modified RCA-RCA protocol |
| Polymerase | Taq Polymerase | AmpliTaq Gold Polymerase (Applied Biosystems) | Polymerase | Taq Polymerase | JumpStart Taq Polymerase (Sigma) | Φ 29 polymerase amount/reaction volume | 80 U/100 μl | 6 U/10 μl | Circularization, T4 DNA ligase amount/reaction volume | 1,000 U/15 μl | 1,350 U/15 μl |
| Polymerase amount/reaction volume | 5 U/60 μl | 2.5 U/20 μl | Polymerase amount/reaction volume | 1.25U/50 μl | 5U/50 μl | Yeast pyrophosphatase | 1 U/ml | Not used | Amplification, Φ 29 polymerase amount/reaction volume | 3 U/20 μl | 8 U/10 μl |
| Temperature profile | 50 cycles (92 °C/1 min, 37 °C/2 min, ramping step 1 °C/10 s to 55 °C, 55 °C/4 min) | 95 °C/11 min | Temperature profile | 95 °C/5 min | 95 °C/3 min | ||||||
| 45 cycles (92 °C/1 min, 25 °C/2 min, ramping step 1 °C/1 s to 60 °C, 60 °C /4 min) | 5 cycles (94 °C/1 min, 30 °C/1 and 5 min, 3-min transition 30–72 °C, 72 °C/3 min) | 5 cycles (94 °C/1 min, 25 °C/1 and 5 min, ramping step 0.2 °C/1 s to 72 °C, 72 °C/3 min) | |||||||||
| 68 °C/10 min | 35 cycles (94 °C/1 min, 62 °C/1 min, 72 °C/3 min) | 40 cycles (94 °C/1 min, 64 °C/1 min, 72 °C/3 min) | |||||||||
| 72 °C/10 min | 72 °C/10 min | ||||||||||
Increase in DNA amount observed for 100, 10, and 1 ng of nondegraded and degraded DNA preamplified with different WGA techniques
| DNA input (ng) | PEP | DOP | MDA | GenomiPhi™ | GenomePlex™ | RCA-RCA | BL-WGA | |
|---|---|---|---|---|---|---|---|---|
| 100 | ND | 12× | 28× | 73× | 40× | 290× | 941× | 244× |
| D | 11× | 15× | 29× | 38× | 120× | 852× | 197× | |
| 10 | ND | 78× | 410× | 1,022× | 810× | 918× | 7,970× | 2,636× |
| D | 25× | 236× | 423× | 334× | 324× | 4,995× | 1,978× | |
| 1 | ND | 395× | 5,620× | 10,034× | 3,619× | 153× | 12,043× | 9,049× |
| D | 144× | 2,032× | 796× | 2,286× | 75× | 10,051× | 8,752× |
ND nondegraded DNA, D degraded DNA
Impact of the amount of preamplified DNA on the quality of SGMPlus profiles when using different WGA methods
| DNA input (ng) | Sample | PEP | DOP | MDA | GenomiPhi™ | GenomePlex™ | RCA-RCA | BL-WGA | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AR (%) | Add peaks | HI (%) | ES (%) | AR (%) | Add peaks | HI (%) | ES (%) | AR (%) | Add peaks | HI (%) | ES (%) | AR (%) | Add peaks | HI (%) | ES (%) | AR (%) | Add peaks | HI (%) | ES (%) | AR (%) | Add peaks | HI (%) | ES (%) | AR (%) | Add peaks | HI (%) | ES (%) | ||
| 100 | ND | 100 | − | >60 | − | 100 | − | 29 | − | 95.2 | − | 49 | − | 100 | − | 54 | − | 80.9 | − | 55 | 26 | 95.2 | + | 10 | − | 85.7 | + | 26 | − |
| D | 90.4 | − | 29 | − | 0 | − | − | − | 0 | − | − | − | 0 | − | − | − | 90.4 | + | 24 | 22 | 76.2 | + | 41 | − | 42.8 | + | 26 | − | |
| 10 | ND | 100 | − | >60 | − | 100 | − | 49 | − | 90.4 | − | 48 | − | 100 | − | 41 | − | 71.4 | + | 56 | 37 | 76.6 | − | 19 | − | 38.0 | − | 56 | − |
| D | 14.2 | − | − | − | 0 | − | − | − | 0 | − | − | − | 0 | − | − | − | 23.8 | − | 29 | − | 9.5 | − | − | − | 52.3 | − | 9 | − | |
| 1 | ND | 100 | − | >60 | − | 100 | − | 50 | − | 95.2 | − | 49 | − | 100 | − | 53 | − | 80.9 | + | 55 | 48 | 14.2 | − | 47 | − | 4.7 | − | − | − |
| D | 4.7 | − | − | − | 0 | − | − | − | 0 | − | − | − | 0 | − | − | − | 19 | − | 33 | − | 0 | − | − | − | 0 | − | − | − | |
| 0.5 | ND | 95.2 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 0.25 | ND | 71.4 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 0.125 | ND | 42.5 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
Alleles recovery calculated as a ratio of the number of amplified loci after WGA preamplification, to the number of alleles present in a nondegraded sample (in percent). In the nondegraded sample, 21 alleles were present (100 %). Alleles with RFU of >50 were counted. Additional peaks (artifacts), not consistent with the lengths of the known alleles present in allelic ladders; present (+), absent (−). HI > 60 % was considered as an acceptable ratio
AR alleles recovery, Add peaks additional peaks, HI the highest heterozygote’s imbalance observed (in percent), ES the highest elevated stutter expressed as a ratio of n-4 area to n allele area (in percent), ND nondegraded DNA, D degraded DNA, NA not analyzed
Fig. 1SGMPlus profiles of triple PEP preamplifications of the same DNA extract and pooled products. PEP was run with 0.25 ng of template. Numbers indicate the percentage of successfully amplified alleles. a, b, c SGMPlus profiles of single, independent PEP reactions. d SGMPlus profile of pooled products
Fig. 2Comparison of SGMPlus profiles of DNA obtained from male muscle tissue. a Nondegraded, native DNA; b DNA degraded to ca 200 bp; c, d, e degraded DNA preamplified by using GenomePlex amplification of 1, 10, and 100 ng, respectively. Asterisk indicates stutters (n-4 fraction)
Amplification results of four Y-chromosome SNP loci for a degraded DNA (100 bp) sample and a FFPE sample before and after GenomePlex preamplification
| Y-chromosome SNP | Amplicon length (bp) | DNA 100 bp | GenomePlex DNA 100 bp | FFPE sample | GenomePlex FFPE sample |
|---|---|---|---|---|---|
| M173 | 68 | + | + | + | + |
| YAP | 150 | + | + | − | + |
| M9 | 164 | − | + | − | + |
| M35 | 513 | − | − | − | − |
(+) positive amplification, (−) lack of amplification
Fig. 3Comparison of HVII regions of nondegraded mtDNA (a) and degraded mtDNA preamplified with GenomePlex (b). The box marks the presence of the A/G heteroplasmy